Sponsor intelligence · OTHER
Clinical trials sponsored by
Guangdong Provincial People'S Hospital.
Real, source-linked trial activity for Guangdong Provincial People'S Hospital: 3 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Aug 5, 2026. Source-linked, daily-refreshed.
PHASE2 2N/A 1
Newest Guangdong Provincial People'S Hospital trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 6d ago | Terbinafine for CSA-AKI Prevention | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 10d ago | Multicenter Prospective Validation of AI Models for Malignancy Risk Pr | N/A | NOT_YET_RECRUITING | ↗ |
| 14d ago | Bevacizumab, Sintilimab, Cetuximab and Irinotecan in Refractory RAS Wi | Ph 2 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Guangdong Provincial People'S Hospital (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.